Sirio Pharma Total Liabilities

Latest as of June 2025: CN¥3.07 Billion CNY ≈ $449.47 Million USD

Sirio Pharma total liabilities. Based on the latest financial reports, Sirio Pharma (300791) has total liabilities worth CN¥3.07 Billion CNY (≈ $449.47 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Sirio Pharma (300791) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Sirio Pharma (2016–2024)

Total liabilities of Sirio Pharma from 2016 to 2024. This chart illustrates how Sirio Pharma's total liabilities have evolved over time, based on quarterly financial data.

Sirio Pharma Competitors by Total Liabilities

The table below lists competitors of Sirio Pharma ranked by their total liabilities.

Company	Country	Total Liabilities
Bloomin Brands Inc NASDAQ:BLMN	USA	$2.68 Billion
Hextar Global Bhd KLSE:5151	Malaysia	RM562.93 Million
Dongfeng Electronic Technology Co Ltd SHG:600081	China	CN¥4.22 Billion
NPK International Inc. NYSE:NPKI	USA	$78.35 Million
Zhejiang Zhengguang Industrial Co. Ltd. SHE:301092	China	CN¥249.99 Million
Besalco Sa SN:BESALCO	Chile	CL$1.05 Trillion
Mid Penn Bancorp NASDAQ:MPB	USA	$5.32 Billion
Medplus Health Services Limited NSE:MEDPLUS	India	Rs19.58 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Sirio Pharma's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Sirio Pharma's balance sheet.

Liquidity & Leverage Metrics

Sirio Pharma Total Liabilities Ratios Explained

Sirio Pharma total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.20	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.54	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sirio Pharma's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sirio Pharma (2016–2024)

The table below shows the annual total liabilities of Sirio Pharma from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥2.84 Billion ≈ $416.29 Million	+8.19%
2023-12-31	CN¥2.63 Billion ≈ $384.79 Million	+77.16%
2022-12-31	CN¥1.48 Billion ≈ $217.20 Million	+16.38%
2021-12-31	CN¥1.28 Billion ≈ $186.62 Million	+173.12%
2020-12-31	CN¥466.95 Million ≈ $68.33 Million	+12.79%
2019-12-31	CN¥414.01 Million ≈ $60.58 Million	-45.49%
2018-12-31	CN¥759.53 Million ≈ $111.14 Million	+7.34%
2017-12-31	CN¥707.58 Million ≈ $103.54 Million	-29.03%
2016-12-31	CN¥997.00 Million ≈ $145.89 Million	--

About Sirio Pharma

SHE:300791 China Packaged Foods

Market Cap

$773.49 Million

CN¥5.29 Billion CNY

Market Cap Rank

#9676 Global

#2415 in China

Share Price

CN¥17.20

Change (1 day)

+2.75%

52-Week Range

CN¥15.63 - CN¥25.86

All Time High

CN¥57.47